Delivery Order SPE2DB24D2101-SPE2DB25FKPPF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,269.40 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on July 16, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy indicated for...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $23,123.28 on August 7, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order, which has an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract, valued at $23,123.28, carries a firm fixed price and requires completion by June 23, 2025. This is a non-set-aside delivery order issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order valued at $14,452.05 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $4,817.35 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for AVEED 750 mg/3 mL vials. This competitively awarded contract, with an ultimate completion date of August 27, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AVEED 750 MG/3 ML vials. This competitive, firm fixed-price delivery order, valued at $2,890.41, was executed on August 22, 2025, with an ultimate completion date of September 15, 2025. The products will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $34,684.92 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 5, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $44,319.62 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on August 7, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order, which was not set aside for small business, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution center in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order has a ceiling value of $96,347.00 and a completion date of May 30, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which also serves as the place of performance—is a major...
- The Defense Logistics Agency awarded a delivery order valued at $9,634.70 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 ml vials on June 18, 2025, with completion targeted for July 11, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPPFDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,853.88 for AVEED 750 mg/3 mL vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy indicated for treating low testosterone in adult males, and this delivery order represents a direct fulfillment of pharmaceutical supply needs within the federal healthcare system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen Drug Corp serves as a critical prime vendor for the Defense Logistics Agency's Medical Supply Chain, supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The company's extensive portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/15/25 |